Resting pulmonary haemodynamics and shunting: a comparison of sea-level inhabitants to high altitude Sherpas by Foster, Glen et al.
 1 
Title: Resting pulmonary haemodynamics and shunting: a 
comparison of sea-level inhabitants to high altitude Sherpas. 
 
Authors: Glen E. Foster1, Philip N. Ainslie1, Mike Stembridge2, Trevor 
A. Day3, Akke Bakker4, Samuel J. E. Lucas5,6, Nia C. S. 
Lewis1, David B. MacLeod7, and Andrew T. Lovering8  
 
Affiliations: 1Centre for Heart, Lung, and Vascular Health, School of 
Health and Exercise Science, University of British Columbia, 
Kelowna, Canada. 
 2School of Sport, Cardiff Metropolitan University, Cardiff, UK. 
 3Department of Biology, Mount Royal University, Calgary, 
Canada. 
 4MIRA Institute, University of Twente; Enschede, the 
Netherlands. 
 5School of Physical Education and Exercise Sciences & 
Department of Physiology, University of Otago, New Zealand 
6School of Sport, Exercise and Rehabilitation Sciences, 
University of Birmingham, Birmingham, United Kingdom. 
 7Department of Anesthesiology, Duke University Medical 
Center, Durham, NC, USA. 
 8Department of Human Physiology, University of Oregon, 
Eugene, USA. 
 
Running head:  Pulmonary haemodynamics and shunts in high altitude 
Sherpas 
 
Keywords:  High altitude, pulmonary hypoxic vasoconstriction, shunt 
 
Word Count: 6805 (Excluding references and figure legends) 
 
TOC Category: Integrative 
 
Correspondence: Glen E. Foster, PhD. 
 
School of Health and Exercise Science 
Faculty of Health and Social Development 
University of British Columbia Okanagan. 
3333 University Way, 
Kelowna, BC, V1V 1V7 
 
Email: glen.foster@ubc.ca 
 2 
Key points summary: 
 Evolutionary pressure to improve gas exchange and/or resting pulmonary 
haemodynamics in hypoxic environments may have led to differences in 
that amount of blood that flows through right-to-left shunt pathways 
between Sherpas and sea-level inhabitants. 
 We studied sea-level inhabitants during rest at sea level and acute 
isocapnic hypoxia and during rest at high altitude following 3 weeks of 
acclimatization and compared their responses to those of Sherpas during 
rest at high altitude. 
 Contrary to some previous literature, we found similar resting pulmonary 
pressure and total pulmonary resistance between acclimatized sea-level 
inhabitants and Sherpas at high altitude. 
 We also found a similar number of subjects from each group with 
intracardiac shunt and intrapulmonary shunt at high altitude. 
 These results help us better understand resting cardiopulmonary 
adaptations to high altitude by comparing life-long high-altitude residents 
with sea-level inhabitants acclimatized to high altitude. 
Word count: 139
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Abstract. 
Incidence of blood flow through intracardiac shunt and intrapulmonary 
arteriovenous anastomoses (IPAVA) may differ between Sherpas permanently 
residing at high altitude (HA) and sea-level (SL) inhabitants as a result of 
evolutionary pressure to improve gas exchange and/or resting pulmonary 
hemodynamics.  To test this hypothesis we compared sea-level inhabitants at SL 
(SL-SL; n=17), during acute isocapnic hypoxia (SL-HX; n=7) and following 3 
weeks at 5,050m (SL-HA; n=8 non-PFO subjects) to Sherpas at 5,050m (n=14).  
SpO2, heart rate, pulmonary artery systolic pressure (PASP) and cardiac index 
(Qi) were measured during 5min of room air breathing at SL and HA, during 
20min of isocapnic hypoxia (SL-HX; PETO2 = 47mmHg) and during 5min of 
hyperoxia (FiO2=1.0; Sherpas only).  Intracardiac shunt and IPAVA blood flow 
was evaluated by agitated saline contrast echocardiography.  Although PASP 
was similar between groups at HA (Sherpas: 30.0±6.0 mmHg; SL-HA: 32.7±4.2 
mmHg; P=0.27), it was greater than SL-SL (19.4±2.1 mmHg; P<0.001).  The 
percent of subjects with intracardiac shunt was similar between groups (SL-SL: 
41%; Sherpas: 50%).  In the remaining subjects, IPAVA blood flow was found in 
100% of subjects during acute isocapnic hypoxia at SL, but in only 4 of 7 
Sherpas and 1 of 8 SL-HA subjects at rest.  In conclusion, differences in resting 
pulmonary vascular regulation, intracardiac shunt and IPAVA blood flow do not 
appear to account for any adaptation to high altitude in Sherpas.  Despite 
elevated pulmonary pressures and profound hypoxaemia, IPAVA blood flow in all 
subjects at HA was lower than expected compared with acute normobaric 
hypoxia. 
 
Abbreviations list: FiO2: fraction of inspired oxygen; HA: High altitude; HPV: 
hypoxic pulmonary vasoconstriction; IPAVA: intrapulmonary arteriovenous 
anastomoses; HR: heart rate; IVC: inferior vena cava; SL: sea level; SL-HA: sea 
level group at high altitude; SL-HX: sea level group during acute hypoxia; SL-SL: 
sea level group at sea-level; SpO2: oxyhaemoglobin saturation; SV: stroke 
volume; PASP: pulmonary artery systolic pressure; PAVM: pulmonary 
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arteriovenous malformation; PFO: patent foramen ovale; Q: cardiac output; Qi: 
cardiac index;  
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Introduction. 
The resting pulmonary haemodynamic response when individuals from lowland 
areas are exposed to high altitude (HA) is reasonably well characterized 
(Reeves, 1973; Swenson, 2013).  For example, hypoxic pulmonary 
vasoconstriction (HPV) is stimulated largely by alveolar partial pressure of 
oxygen (PAO2) and ventilation-perfusion relationships leading to increases in 
pulmonary artery pressure (Marshall & Marshall, 1983).  At sea level (SL), this 
response to regional alveolar hypoxia might be considered adaptive, as its 
teleological role is to decrease perfusion of poorly ventilated alveoli and assist in 
the matching of ventilation and perfusion throughout the lung (Marshall et al., 
1981; Orchard et al., 1983).  However, when the whole lung is hypoxic, such as 
with chronic exposure to high altitude, HPV may in fact be a maladaptive 
response leading to high perfusion pressure, capillary damage, and an increased 
risk of high altitude pulmonary oedema.  High altitude residents from the Andes 
are prone to chronic mountain sickness and greater hypoxaemia, pulmonary 
vasoconstriction and increased haematocrit contribute to their increased 
pulmonary arterial vascular pressure (Penaloza & Arias-Stella, 2007; Stuber & 
Scherrer, 2010).  However, not all high altitude ethnic groups are prone to 
elevated pulmonary artery pressures and chronic mountain sickness, which 
suggests that some individuals and populations of high-altitude residents have 
different phenotypes for life in environments with low PO2.  Tibetans and 
Sherpas, for example, are thought to be well adapted to high altitude owing partly 
to their relatively low pulmonary artery pressures, minimal polycythemia, elevated 
resting ventilation, and a high lung diffusing capacity (Groves et al., 1993; Hoit, 
2005; Hoit et al., 2011; Faoro et al., 2013).  Although we do not contest that 
Tibetans and Sherpas are well-adapted to their high altitude environment, the 
direct evidence for low resting pulmonary artery pressures with alveolar hypoxia 
in this high-altitude population is based on investigations with small sample sizes 
and lack adequate control groups.  To shed light on resting pulmonary 
haemodynamics in Sherpas, it would be most appropriate to study resting 
pulmonary haemodynamics in high altitude Sherpas and in sea-level inhabitants 
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at sea level and following acclimatization to high altitude. 
 The circulatory system has two pathways that could help to alleviate 
pulmonary pressure by providing a low resistance pathway for blood.  However, 
these pathways also prevent some blood from passing through the blood gas 
interface within the lung, which could impair pulmonary gas exchange efficiency.  
These pathways include intracardiac shunt, of which the most notable is the 
patent foramen ovale (PFO), and intrapulmonary arteriovenous anastomoses 
(IPAVA).  A PFO is detected in 35-38% of the general population (Woods, 2010; 
Marriott et al., 2013; Elliott et al., 2013).  Whereas, blood flow through IPAVA is 
detected at rest in approximately 30% of healthy humans at SL (Woods, 2010; 
Elliott et al., 2013) and increases to near 100% in healthy male and female 
humans during exercise (Eldridge et al., 2004; Stickland et al., 2007; Kennedy et 
al., 2012) and with exposure to hypoxia (Imray et al., 2008; Lovering et al., 
2008a; Laurie et al., 2010).  At lower altitudes, e.g. <3000m, the presence of a 
right-to-left shunt pathway, such as a PFO or IPAVA, could potentially worsen 
systemic arterial hypoxaemia and over-time lead to greater pulmonary 
hypertension, suggesting blood flow through these pathways could be 
detrimental (Levine et al., 1991; Swenson & Bärtsch, 2012).  However, with 
increasing altitude, the impact of blood flow through IPAVA and/or PFO on 
pulmonary gas exchange efficiency will decrease as PaO2 approaches PvO2.  
Accordingly, at altitudes > 3000m, blood flow through these pathways may 
provide a beneficial effect by allowing for lower pulmonary vascular pressure 
without having a significant impact on gas exchange.  Based on this rationale, 
there is reasonable ground to investigate whether or not Sherpas, a group of 
well-adapted high altitude residents living in the Himalayas, may have adapted to 
utilize large diameter right-to-left shunt pathways when hypoxaemic to divert 
blood flow away from the conventional pulmonary circulation in an attempt to 
reduce pulmonary vascular pressure for a given level of HPV. 
 With this rationale in mind, we aimed to measure pulmonary 
haemodynamics, SpO2 and to characterize the occurrence of intracardiac shunt 
and blood flow through IPAVA in Sherpas who permanently reside at high 
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altitude compared to sea-level inhabitants at sea level and following ~3 weeks 
acclimatization to 5,050m.  To provide a reasonable comparison to acute hypoxia 
studies investigating pulmonary haemodynamics and right-to-left shunt (Laurie et 
al., 2010), we studied the pulmonary haemodynamic response in a subset of 
sea-level subjects during exposure to acute isocapnic hypoxia.  Based on the 
results of previous investigations (Groves et al., 1993; Hoit, 2005; Schwab et al., 
2008; Stuber & Scherrer, 2010; Hoit et al., 2011; Groepenhoff et al., 2012; Faoro 
et al., 2013) we hypothesized that Sherpas at high altitude would have low 
pulmonary vascular pressure similar to sea-level inhabitants at sea level and 
would have decreased pulmonary vascular pressure compared to sea-level 
inhabitants following acclimatization to high altitude.  Secondly, we hypothesized 
that the lower pulmonary artery vascular pressure in Sherpas at altitude would be 
explained by more blood flow through right-to-left shunt pathways compared with 
sea-level inhabitants.  Such differences might help to explain the previously 
reported reduced pulmonary pressure and total pulmonary resistance in Sherpas 
compared with sea-level inhabitants.  
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Methods. 
Ethical approval.  All experimental procedures and protocols were submitted to, 
and approved by the Clinical Research Ethics Board at the University of British 
Columbia and the Nepal Health Medical Research Council, and conformed to the 
latest revision of the Declaration of Helsinki.  All participants provided written 
informed consent prior to participation in this study. 
 
Subjects.  We studied a group of sea-level subjects in Kelowna, British 
Columbia, Canada near sea level (SL-SL; n= 17; elevation = 344m).  From this 
group, a subset of subjects were identified as PFO negative and were 
subsequently studied for pulmonary haemodynamics and blood flow through 
IPAVA at sea level during acute isocapnic hypoxia (n=7) and at high altitude 
following 3 weeks of acclimatization at the EV-K2-CNR Laboratory (SL-HA; n=8; 
elevation = 5,050m).  Three weeks of exposure to high altitude was selected to 
ensure a reasonable length of time for acclimatization.  Previous work by Lundy 
et al. (2004) have demonstrated that there is little difference in arterial 
oxyhaemoglobin saturation (SpO2) and haematocrit between 2 and 8 weeks of 
acclimatization to 4,100m.  Due to logistical barriers one subject in the SL-HA 
group was not studied during acute isocapnic hypoxia at sea level.  Sea-level 
subjects were excluded if they were born above 1,200m in elevation or if they 
had travelled to high altitude (>2,500m) in the past 6 months.  Finally, a group of 
high-altitude residents of Sherpa ancestry were recruited from high-altitude 
regions of the Khumbu Valley and were studied at high altitude (n=14; elevation 
= 5,050m).  Sherpas were excluded if they were not permanent residents above 
2,800m, if they were born below an altitude of 2,800m, and if they did not self-
identify as a Sherpa.  No Sherpas had travelled below 2,800m within 2 months of 
this study. 
 
Experimental Protocol.  At both sea level and high altitude, all subjects were 
first measured for height and weight and then instrumented with an intravenous 
catheter at the antecubital fossa.  Following 5 minutes of supine rest, three 
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consecutive blood pressure measurements were obtained from the right upper 
arm by using a manual sphygmomanometer and stethoscope for auscultation of 
Korotkoff sounds.  Also, at this time, SpO2 (Model 3100, WristOx, Nonin Medical 
Inc., MN, USA) was measured by pulse oximetry of the right index finger.  While 
in the supine position, collapse of the inferior vena cava (IVC) during a rapid 
inspiration was imaged by ultrasound to estimate right atrial pressure 
(Yildirimturk et al., 2011).  The subject was then positioned laterally on their left 
side and echocardiographic images were recorded to determine stroke volume 
(SV) and pulmonary artery systolic pressure (PASP).  Heart rate (HR) was 
measured by standard three-lead electrocardiograph.  Next, an apical 4-chamber 
view of the heart was acquired and the presence or absence of intracardiac 
shunt or blood flow through IPAVA was determined by the technique of agitated 
saline contrast echocardiography (Kennedy et al., 2012; Elliott et al., 2013).  This 
was repeated during the release of a Valsalva maneuver as a provocative 
stimulus to ensure the patency of the foramen ovale was identified appropriately.  
At sea level, subjects identified as PFO negative were subsequently exposed to 
20 minutes of isocapnic hypoxia to determine pulmonary haemodynamics and 
blood flow through IPAVA during an acute hypoxic exposure.  Pulmonary 
haemodynamics and blood flow through IPAVA were measured during the last 5 
minutes of hypoxia.  In Sherpas only, at high altitude the above measurements 
were repeated after breathing hyperoxia (FiO2 = 1.0) for 5 minutes to determine 
the impact of hypoxia relief.  Agitated contrast studies were repeated if there was 
any doubt in the classification of the shunt to intracardiac or intrapulmonary. 
 
Pulmonary Hemodynamics.  All echocardiography measurements were 
performed using the same commercially available ultrasound system (Vivid Q, 
3.5 MHz transducer, GE Healthcare) by the same trained sonographer (M.S.).  
First, the diameter of the left ventricular outflow tract at the level of the aortic 
annulus was determined from the parasternal long axis view.  Measurements 
were taken at the end of systole and the average of three cardiac cycles taken as 
the diameter of the aorta.  Then, the velocity time integral (VTI) of the left 
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ventricular outflow tract was obtained from an apical five-chamber view by 
placing a pulsed wave Doppler sample volume just within the aortic valve.  SV 
was calculated as the product of the VTI and aortic area, and Q was obtained by 
multiplication with HR.  These methods have been previously described and 
validated against thermodilution and direct Fick (Christie et al., 1987).  Cardiac 
index (Qi) was determined by indexing Q with body surface area to facilitate 
comparisons between groups.  Tricuspid regurgitation peak velocity was 
measured by continuous-wave Doppler ultrasound using color flow imaging from 
the apical four-chamber view.  The pulmonary artery pressure gradient could 
then be estimated from the simplified Bernoulli equation and PASP could be 
estimated by addition of right atrial pressure.  The IVC diameter was measured 
from subcostal longitudinal images approximately 2 cm distal to the right atrial 
junction.  The collapsibility index was calculated as the percentage of difference 
between maximal and minimal size of IVC.  Right atrial pressure was predicted 
using the collapsibility index as recommended by the American Society of 
Echocardiography (Lang et al., 2005).  This method has been validated against 
right atrial pressure obtained directly by right heart catheterization (Yildirimturk et 
al., 2011).  All pulmonary haemodynamic measurements were made on three 
cardiac cycles and averaged to provide a single value.  Total pulmonary 
resistance was estimated by indexing PASP against Q (i.e. PASP/Q; mmHg l-1).  
This noninvasive estimate of total pulmonary resistance correlates well with 
invasive measurements (Abbas et al., 2003; Roule et al., 2010). 
 
Agitated Saline Contrast Echocardiography.  The presence of intracardiac 
shunt (i.e. PFO) was determined under resting conditions and during a 
provocative stimulus (i.e. release from Valsalva) using the technique of agitated 
saline contrast echocardiography (Marriott et al., 2013).  Two, 5-ml syringes were 
connected by three-way stopcocks and connected to the 22-guage cannula 
placed in the antecubital vein.  One syringe contained 4 ml of sterile saline and 
the other contained 0.5 ml of air.  The two syringes were flushed back and forth 
forcefully to agitate the mixture prior to rapid injection.  The agitated contrast was 
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visualized travelling through the heart from an apical 4-chamber view of the 
heart.  If a negative test was identified, a provocative maneuver was used to 
further assess the patency of the foramen ovale.  In this case, subjects were 
instructed to valsalva at the end of a normal expiration.  Agitated contrast was 
subsequently injected and once visualized in the right atrium, the subjects were 
asked to relax and breathe quietly.  A PFO was identified if contrast appeared in 
the left ventricle within <5 cardiac cycles after the contrast cloud filled the right 
atrium (Marriott et al., 2013).  After all contrast injections, a minimum of 20 
cardiac cycles was recorded.  In the event that a subject was identified as being 
PFO negative they were then studied for resting blood flow through IPAVA.  An 
IPAVA was defined when contrast appeared in the left ventricle 6 or more cardiac 
cycles after the contrast appeared in the right atrium.  Therefore, all subjects 
were identified as PFO positive or negative and IPAVA positive and negative.  A 
PFO positive subject could also have blood flow through an IPAVA, but this 
technique cannot distinguish between the two.  As a result, blood flow through 
IPAVA can only be studied in subjects identified as PFO negative.  This 
technique has been used to investigate blood flow through IPAVA in subjects 
during rest and exercise at SL breathing room air and during acute normobaric 
hypoxia (Stickland et al., 2004; Imray et al., 2008; Kennedy et al., 2012; Laurie et 
al., 2012; Elliott et al., 2013).  A scoring system was used to determine the 
severity of blood flow through IPAVA based on the greatest density and spatial 
distribution of microbubbles in the left ventricle of a single cardiac cycle during 
the subsequent 20 cardiac cycles (Lovering et al., 2008b).  This 0-5 scoring 
system assigns a ‘0’ for no microbubbles; ‘1’ for 1-3 microbubbles; ‘2’ for 4-12 
microbubbles; ‘3’ for greater than 12 microbubbles bolus; ‘4’ for greater than 12 
microbubbles heterogeneously distributed; and a ’5’ for greater than 12 
microbubbles homogeneously distributed.  All echocardiograms were conducted 
and analyzed by the same un-blinded investigator (M.S.).  Previous work by 
members of our group has shown good agreement between scorers who have 
been blinded to the experimental conditions (Laurie et al., 2010). 
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Isocapnic Hypoxia.  Respiratory parameters were acquired at 200Hz using an 
analog-to-digital converter (PL3504, ADInstruments, Colorado Springs, USA) 
interfaced with a personal computer and analyzed using commercially available 
software (LabChart, ADInstruments, Colorado Springs, USA).  During the 
isocapnic hypoxia protocol subject’s breathed through a mouthpiece and two-way 
non-rebreathing valve, and a nose clip was applied to obstruct the nasal 
passage.  Respired gas pressures were sampled at the mouth and analyzed for 
PO2 and PCO2 (ML206, ADInstruments, Colorado Springs, USA).  Respiratory 
flow was measured at the mouth using a pneumotachograph (HR 800L, 
HansRudolph, Shawnee, USA).  PETO2, PETCO2, inspiratory and expiratory tidal 
volume was determine for each breath online using custom designed software 
(LabView, National Instruments, Austin, USA). SpO2 was measured continuously 
by pulse oximetry (ML320/F, ADInstruments, Colorado Springs, USA).  PETO2 
was maintained at 45 mmHg and PETCO2 was maintained at resting levels by 
using a portable end-tidal forcing system (AirForce, G.E.Foster, Vancouver, 
Canada)(Querido et al., 2013; Bain et al., 2013).  This system uses independent 
gas solenoid valves for O2, CO2, and N2 and controls the volume of each gas 
being delivered to an inspiratory reservoir through a mixing and humidification 
chamber.  Using feedback information regarding PETO2, PETCO2, inspired and 
expired tidal volumes, and estimates of O2 consumption and CO2 production the 
system prospectively targets the inspirate using the alveolar gas equation to 
bring end-tidal gas levels to the desired level.  Gas control fine-tuning is 
accomplished using a complex feedback control and error reduction algorithm.  
Pulmonary haemodynamics and blood flow through IPAVA were determined 
during 5 min of baseline breathing and during the last 5 minutes of isocapnic 
hypoxia. 
 
Statistical Analysis.  Statistical comparisons and calculations were made using 
statistical software (Statistica v.7.0, Statsoft Inc., Tulsa, OK, USA).  Subject 
resting characteristics were compared between the three groups by one-way 
analysis of variance.  Pulmonary haemodynamics were compared between 
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groups by a one-way ANOVA.  For all analyses, when significant F-ratios were 
detected, Tukey’s HSD was applied and corrected for unequal sample sizes 
where appropriate to determine where the differences lay.  Differences between 
haemodynamic parameters were compared within each group for PFO+ and 
PFO- subjects by un-paired T-test.  Fisher’s exact test was used to compare the 
frequency of intracardiac shunt and IPAVA between groups.  Shunt score was 
compared between groups by Friedman’s test, with Dunn’s posttest if 
appropriate.  All data are presented as mean ± SD (unless otherwise noted) and 
statistical significance was set at P<0.05 for all comparisons. 
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Results. 
Subject characteristics and resting haemodynamic data are presented in Table 1.  
Groups were similar in age, but only SL-SL was taller than Sherpas (P<0.05). 
Body mass for all three SL groups was similar, but only SL-HX and SL-HA were 
significantly heavier than Sherpas (P<0.05).  Body mass index (BMI) was similar 
between groups but body surface area was greater in SL-SL, SL-HX and SL-HA 
compared with Sherpas.  SpO2 was lowered similarly during acute hypoxia and 
HA (P<0.001), and was similar between SL-HA and Sherpas.  Likewise, HR was 
elevated during acute hypoxia and HA (P<0.001) but was similar between groups 
exposed to hypoxia.  Both MAP and Qi were not appreciably different between 
the four groups.  Table 2 displays the geographical locations and altitude of 
where Sherpas were born. 
Figure 1A displays PASP for all groups, including sea-level subjects 
during acute hypoxia and Sherpas during hyperoxia breathing.  Acute hypoxia 
and high altitude increased PASP in SL-HX and SL-HA to a level similar to that of 
Sherpas.  Hyperoxia decreased PASP in Sherpas (P<0.01); however, PASP was 
still greater than that observed in the SL-SL group (P<0.01).  Figure 1B displays 
total pulmonary resistance as estimated by PASP/Q.  Total pulmonary resistance 
was elevated at high altitude in the SL-HA group, but was not significantly 
different from Sherpas.  Hyperoxia had no effect on total pulmonary resistance in 
Sherpas.  Total pulmonary resistance was not significantly elevated during acute 
hypoxia owing to a small (albeit statistically insignificant) increase in Qi.  
 Figure 2 shows a contrast echocardiogram for one Sherpa at 5,050m who 
was identified as having a resting intracardiac shunt.  Figure 3A displays the 
percent of subjects positive for intracardiac shunt in Sherpas and SL-SL.  In 
Sherpas, 7 out of 14 subjects were positive for intracardiac shunt, which was not 
statistically different from SL-SL where 7 out of 17 subjects were positive for 
intracardiac shunt.  There were no significant differences between PFO positive 
and PFO negative subjects in either sea level subjects or Sherpas (Table 1 and 
Figure 1). 
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In both SL-SL and Sherpas, 5 out of 7 intracardiac shunts were identified in the 
resting state without valsalva.  Eight subjects studied at sea level were negative 
for both intracardiac shunt and resting blood flow through IPAVA and were 
subsequently studied during acute isocapnic hypoxia (n=7 only) and at 5,050m 
(i.e. SL-HA) to determine the presence of hypoxia-induced blood flow through 
IPAVA.  Similarly, seven Sherpas were negative for intracardiac shunt and were 
subsequently studied for resting blood flow through IPAVA at 5,050m.  Figure 3B 
shows the percent of subjects identified for resting blood flow through IPAVA 
during acute hypoxia and at high altitude.  During acute isocapnic hypoxia 
exposure, 100% of subjects displayed blood flow through IPAVA.  At high altitude 
the proportions were much less and not statistically different between Sherpas 
and SL-HA.  Nonetheless, 4 out of 7 Sherpas and 1 out of 8 SL-HA were 
identified as having a resting IPAVA at high altitude.  In addition, blood flow 
through IPAVA remained in 3 out of 4 Sherpas breathing 100% O2.  Figure 4 
shows two contrast echocardiograms in one Sherpa who had a resting blood flow 
through IPAVA at 5,050m (Figure 4A) and while breathing 100% O2 (Figure 4B). 
 The magnitude of blood flow through IPAVA for all subjects at high altitude 
was low.  At 5,050m all subjects who were positive for blood flow through IPAVA 
at rest had a microbubble score of ‘1’ while breathing ambient air.  While 
breathing hyperoxia, one Sherpa had a microbubble score of ‘2’ with the 
remaining two Sherpas having a score of ‘1’ (i.e., 1 subject increased their score 
with hyperoxia while 1 subject normalized their response).  We did not observe a 
microbubble score for blood flow through IPAVA greater than ‘2’ in any subject 
during any experimental conditions. 
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Discussion. 
This is the first study to simultaneously examine pulmonary 
haemodynamics, presence of intracardiac shunt, and blood flow through IPAVA 
between Sherpas and acclimatized sea-level inhabitants at high altitude.  The 
major findings from this study indicate that (1) there are no differences in resting 
pulmonary haemodynamics between acclimatized sea-level inhabitants and 
Sherpas, and (2) blood flow through shunt pathways do not appear to contribute 
to high altitude adaptation in Sherpas.  Principally, we found that pulmonary 
arterial pressure and total pulmonary resistance were similar between Sherpas at 
high altitude and sea-level inhabitants following 3 weeks of acclimatization.  In 
addition, we found a similar number of subjects with intracardiac shunt and blood 
flow through IPAVA between Sherpas and sea-level inhabitants.  Despite 
elevated pulmonary pressures and profound hypoxaemia at high altitude, the 
number of subjects with blood flow through IPAVA and the magnitude of blood 
flow through IPAVA for a given level of hypoxaemia in all subjects was lower than 
expected based on: (1) acute isocapnic hypoxia testing at sea-level in a subset of 
our SL subjects, and (2) from the results of previous investigations involving 
acute normobaric hypoxia (Laurie et al., 2010; Elliott et al., 2011).  The lack of 
difference in cardiac output between high-altitude and sea level measurements 
may be one explanation for the lower than expected blood flow through IPAVA.  
Another explanation may relate to pulmonary vascular remodeling to high altitude 
in both sea-level inhabitants and Sherpas.  Relevant methodological 
considerations and evidence to support these conclusions will now be discussed. 
 
Pulmonary haemodynamics and adaptation to high altitude.  In 
humans, there are several populations of life-long high-altitude residents 
including the residents of Leadville, Colorado in North America (Reeves & 
Grover, 1975), the Andean natives of South America (Banchero et al., 1966; 
Schwab et al., 2008; Groepenhoff et al., 2012), the Amhara highlanders in 
Ethiopia (Hoit et al., 2011) and the Tibetans from the Himalayas (Groves et al., 
1993; Hoit, 2005) who have been studied for pulmonary adaptations to high-
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altitude environments.  Of this group of high-altitude residents, the Tibetans have 
been reported to have the lowest mean pulmonary pressure at rest and display 
no rise in pulmonary vascular resistance (Groves et al., 1993; Hoit, 2005).  
Tibetans have been reported to exhibit little hypoxic pulmonary vasoconstriction 
as evidenced by no change in pulmonary vascular resistance with hyperoxia 
breathing (Groves et al., 1993).  However, the operation Everest II studies also 
demonstrated in healthy lowlanders that elevated pulmonary resistance with 
high-altitude exposure was not immediately reversed by hyperoxia (Groves et al., 
1987). 
Sherpas are another group of high-altitude natives from the Himalayan 
plateau who share recent ancestry with the Tibetan highlanders (Hochachka, 
1998).  Pulmonary haemodynamics have previously been assessed directly in 
five Tibetan highlanders by right heart catheterization and studied during rest at 
3,658m and with further hypoxic stress (14% O2) (Groves et al., 1993).  Mean 
pulmonary pressure, cardiac output, and pulmonary vascular resistance were 
reported to be unchanged with exposure to hypoxia and not different from sea-
level norms.  A closer assessment of individual subject data indicates that a 
limitation in statistical power may have prevented the detection of hypoxia-
induced pulmonary vasoconstriction.  Specifically, three out of five subjects 
increased pulmonary vascular resistance markedly (range of the difference = -0.2 
– +2.2 woods units).  However, it is difficult to compare our data with this study 
(Groves et al., 1993) due to differences in techniques (i.e. right heart 
catheterization vs. echocardiography).  Instead, the direct comparison of our 
group of Sherpas to the group of Tibetans studied by Hoit and colleagues (Hoit, 
2005) is more valid since similar techniques and methodology were used (albeit 
at slightly different altitudes).  Specifically, we found similar PASP (mean ± SE; 
30.0 ± 1.6 vs 31.5 ± 1.0 mmHg), Qi (2.2 ± 0.1 vs 2.7 ± 0.8 l/min/cm2), and total 
pulmonary resistance (8.2 ± 0.6 vs 8.5 ± 0.4) between our Sherpas and the 
Tibetans of Hoit et al. (2005), respectively.  Recently, Faoro et al. (2013) 
assessed pulmonary haemodynamics and gas exchange at rest and during 
exercise in Sherpas.  They estimated mean pulmonary artery pressure using a 
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prediction equation from the measurement of PASP and subsequently calculated 
PVR.  In that study, the authors compared their measurements made in Sherpas 
to measurements made in a control group of sea-level inhabitants within two 
days of arrival at 5,050m.  In our experience, 40-50% of subjects will have 
symptoms of AMS during this time-point and be in the very early stages of 
acclimatization (i.e., more hypoxaemic with little renal compensation for the 
respiratory alkalosis) (Fan et al., 2010; Lucas et al., 2011; Willie et al., 2013); 
therefore, comparison with Sherpas at this time-point seems problematic.  Here, 
we compared our findings in Sherpas to a group of sea-level inhabitants both at 
sea level and following ~3 weeks of acclimatization to high altitude and our 
subjects were free of AMS symptoms and therefore we believe this to be a more 
appropriate comparison.  Our data showed that while PASP and total pulmonary 
resistance in the Sherpas were significantly elevated compared to sea-level 
inhabitants at sea level, following acclimatization sea-level inhabitants and 
Sherpas did not differ in terms of PASP and total pulmonary resistance (see 
figure 1A and 1B).  Based on these results and direct comparisons, we suggest 
that Sherpas and Tibetans have similar pulmonary haemodynamics at high 
altitude and they do not differ substantially from sea-level inhabitants following 
acclimatization to high altitude. 
 
Intracardiac shunt.  Agitated saline contrast echocardiography is a highly 
sensitive technique useful in identifying intracardiac shunts (Marriott et al., 2013).  
The prevalence of intracardiac shunting in the general population (sample sizes 
ranging from 104 – 1162 subjects) has been estimated to be 35-38% (Woods, 
2010; Marriott et al., 2013; Elliott et al., 2013).  In the current investigation, we 
characterized the occurrence of intracardiac shunt in a relatively small sample of 
subjects at sea-level and Sherpas at high altitude.  The observed occurrence of 
intracardiac shunt in our groups of subjects is consistent with previous reports 
(Woods, 2010; Marriott et al., 2013; Elliott et al., 2013).  We detected intracardiac 
shunt in 41% of sea-level inhabitants; a finding not statistically different from our 
Sherpa population, where intracardiac shunt was detected in 50% of subjects 
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(see figure 3).  Although Valsalva was used as a provocative maneuver to verify 
the patency of the foramen ovale, intracardiac shunts were detected in the 
majority of subjects (~83%) at rest without requiring a provocative maneuver.  
This indicates that the majority of PFO positive subjects had an intracardiac 
shunt in the resting state while at high altitude.  Despite this, the amount of blood 
flow through the PFO did not lead to a measureable effect on SpO2 and 
pulmonary vascular pressure between PFO positive and negative subjects at 
altitude. Therefore, at least in this population, the prevalence of intracardiac 
shunt is similar between Sherpas and sea-level inhabitants and the amount of 
right-to-left shunt was small enough such that there was no appreciable impact 
on saturation or pulmonary vascular pressure at 5,050m. Of note, in subjects 
breathing an FiO2 between 0.10 and 0.12, which is equivalent to an altitude of 
5,050m, we have previously calculated that the total venous admixture would 
need to be >25% in order to account for all of the pulmonary gas exchange 
efficiency that occurs with this level of hypoxia (Laurie et al., 2010).  Thus, at 
5,050m, a significantly large amount of shunt would be required to have an 
impact on saturation and/or pulmonary gas exchange efficiency.  However, this 
does not preclude that the presence of a PFO would have a larger impact on 
saturation and gas exchange at lower altitudes where shunt fractions on the 
order of 5-8% would have a significant effect on pulmonary gas exchange 
efficiency (Laurie et al., 2010). 
 
Blood flow through IPAVA.  Agitated saline contrast echocardiography is the 
only non-invasive means of assessing blood flow through IPAVA in PFO negative 
subjects.  Using this technique, blood flow through IPAVA at rest is detectable in 
30% of healthy humans who are PFO negative (Elliott et al., 2013), but the 
prevalence increases to nearly 100% in healthy humans during exercise 
(Eldridge et al., 2004; Stickland et al., 2007; Kennedy et al., 2012) and with 
exposure to acute normobaric hypoxia (Lovering et al., 2008a; Laurie et al., 
2010).  In the current study, we also found that 100% of subjects exposed to 20 
minutes of isocapnic hypoxia had blood flow through IPAVA (see Figure 2B).  
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Several mechanisms could be responsible for the opening of IPAVA including: 
(1) the hypoxic stimulus; (2) increases in pulmonary vascular pressure, or (3) 
increases in cardiac output.  Laurie et al. (2010) found that the number of 
subjects with blood flow through IPAVA increased with reductions in FiO2.  For 
example, it was noted that 100% of subjects had blood flow through IPAVA while 
breathing a 10% oxygen mixture for 30 minutes.  In addition, the magnitude of 
blood flow through IPAVA (i.e., microbubble score) increased with reductions in 
FiO2 and was related to changes in SpO2 and PASP.  The result from their study 
provides correlational evidence to indicate that blood flow through IPAVA 
contributes to the total venous admixture.  In direct contrast to these results, we 
found very little evidence of blood flow through IPAVA in sea-level inhabitants 
after living at high altitude for 3 weeks, nor in Sherpas permanently living at high 
altitude (see figure 3B).  In those subjects who demonstrated blood flow through 
IPAVA the magnitude estimated by microbubble score was small (i.e., <2) and 
therefore seems unlikely to have contributed appreciably to the total venous 
admixture. The discrepancies between studies are potentially explained by 
differences in normobaric versus hypobaric hypoxia, the impact of acclimatization 
on cardiac output and/or vascular remodeling.  Interestingly, 100% of subjects 
exposed to acute isocapnic hypoxia at sea level were found to have blood flow 
through IPAVA and they had a larger rise in cardiac output compared to subjects 
at high altitude.  This indicates that increases in cardiac output may be a stimulus 
for blood flow through IPAVA.   
An increase in right heart cardiac output and the associated pulmonary 
vascular shear stress has been suggested as a stimulus capable of increasing 
blood flow through IPAVA; since when cardiac output is increased by 
dobutamine, dopamine, or epinephrine there is a predictable increase in the 
microbubble score (Laurie et al., 2012; Bryan et al., 2012).  In our investigation, 
the lack of detectable blood flow through IPAVA in Sherpas and sea-level 
inhabitants at high altitude could be explained by the fact that cardiac output did 
not differ from our sea-level inhabitants measured at sea level.  Bryan et al 
(2012) intravenously delivered dobutamine in increasing doses to increase 
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cardiac output.  They found that the microbubble score, PASP, and the 
physiological shunt fraction (Qs/Qt) increased in relation to cardiac output.  
Therefore, blood flow through IPAVA with both acute hypoxia and exercise could 
potentially be explained by an increase in cardiac output.  
An alternative explanation for the lack of blood flow through IPAVA with 
chronic hypoxia could relate to the remodeling of the pulmonary vasculature.  
While it is not clear to what extent vascular remodeling will affect IPAVA, small 
pulmonary arteries, which normally have very little smooth muscle, increase the 
expression of α-smooth muscle actin, and larger pulmonary arteries develop 
thickened media and adventitia (Stenmark et al., 2006).  Interestingly, the time 
course of pulmonary vascular remodeling is surprisingly quick upon exposure to 
high altitude with adventitial fibroblasts and medial smooth muscle cells 
increasing DNA synthesis after about three to six days of high-altitude exposure 
(Stenmark et al., 2006).  In addition, mRNA levels for procollagens and 
fibronectin are significantly elevated in lung parenchyma tissue of rats following 
exposure to as little as three days of hypoxia (Berg et al., 1998).  Whether or not 
IPAVA increase the number of smooth muscle cells or the thickness of their 
adventitia or media with chronic hypoxia is unknown.  One intriguing hypothesis 
suggests that IPAVA act as pressure relief valves to protect the delicate 
pulmonary capillaries.  In line with this hypothesis, IPAVA may provide a low 
resistance pathway for blood to travel and thus prevent capillary damage caused 
by high pulmonary vascular pressure.  With chronic hypoxia, as vascular 
remodeling ensues and the pulmonary vasculature’s ability to handle high 
pulmonary pressure is improved, the need for blood flow through IPAVA may be 
substantially reduced to augment the amount of blood flow through the lung’s gas 
exchange surfaces. 
 
Limitations.  We found that 3 out of 4 Sherpas had resting blood flow through 
IPAVA at high altitude breathing 100% O2. It has been previously shown that 
breathing 100% O2 prevents blood flow through IPAVA during exercise (Lovering 
et al., 2008b; Elliott et al., 2011) and in 80% of resting subjects who demonstrate 
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blood flow through IPAVA (Elliott et al., 2013). In the study by Elliott et al, we also 
reported that a subset of healthy young asymptomatic subjects (6/31 or 20%) 
with blood flow through IPAVA at rest (near sea level) continue to have blood 
flow through IPAVA despite breathing 100% O2.  Although one explanation may 
be that these subjects had pulmonary arteriovenous malformations (PAVMs) that 
allowed blood to flow through them despite the fact that these subjects were 
breathing 100% O2, it is currently unknown whether or not hyperoxia only acts to 
prevent blood through IPAVA and not PAVMs.  Because PAVMs are considered 
to be rare and associated with diseases such as hereditary hemorrhagic 
telangiectasia, it is unlikely that these healthy asymptomatic young subjects had 
PAVMs but may simply have blood flow through IPAVA despite breathing 100% 
O2, for reasons that are currently unexplainable.  Of note, at 5,050m, alveolar 
PO2 would be approximately half of that in subjects breathing 100% O2 at sea 
level, so it is possible that the alveolar PO2 may not be sufficient to close the 
IPAVA in Sherpas at this altitude.  We acknowledge the possibility that some of 
our Sherpas may have pulmonary arteriovenous malformations (PAVMs) that are 
non-reactive to changes in FiO2.  Therefore, it is possible that we measured 
blood flow through PAVMs rather than IPAVA and Sherpas could potentially be 
free from IPAVA.  However, based on our work in young asymptomatic subjects, 
it is also entirely plausible that our Sherpas may have IPAVA that are 
unresponsive to hyperoxia.  This is supported by the fact that Sherpas and sea-
level inhabitants during acclimatization to high altitude had similar microbubble 
scores during rest at high altitude.  Future research could study Sherpas during 
exercise to determine if such a provocative stimulus could open up IPAVA to a 
greater degree than during rest at high altitude. 
 Statistical power can be a problem in many high altitude field studies and 
this increases the risk of a type-II error.  While we are confident that the 
proportion of our subjects who were identified as having a PFO (41% of sea-level 
subjects and 50% of Sherpas) is a good reflection of the prevalence in the 
general population, we are less confident in the proportions of subjects with 
resting blood flow through IPAVA.  This is because after removal of the subjects 
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with PFOs, our sample size is decreased by a half.  Although we conclude that 
the number of subjects with resting blood flow through IPAVA at high altitude (1 
of 8 SL-HA subjects and 4 of 7 Sherpas) is similar we recommend that future 
research is required to reconcile these similarities in a larger sample.  The 
strength of our study lies in determining the differences between PASP in 
Sherpas and low-landers.  Since we are able to compare measurements in 
Sherpas with measurements made in sea-level inhabitants at sea-level and after 
acclimatization to high altitude, it is unlikely that a type-I error was made. 
 Acute hypoxia at sea-level was performed under isocapnic conditions.  
Although a poikilocapnic response test may have been a more appropriate 
comparison we do not anticipate that this difference in protocol would have a 
negative impact on our results.  Microbubble scores obtained with isocapnic 
hypoxia are not significantly different from microbubble scores obtained 
previously using a poikilocapnic hypoxia protocol (Laurie et al., 2010).  Rather 
the purpose of this acute hypoxia protocol provides confidence that the data 
obtained from our sea-level subjects is similar to other published reports in sea-
level subjects and helps to improve interpretation of the lack of blood flow 
through IPAVA detected while at high altitude. 
  Finally, total pulmonary resistance could be affected by the relationship of 
haematocrit and blood viscosity.  For example, a 10% increase in haematocrit 
(45% - 55%) would lead to approximately a 20% increase in relative viscosity 
(Hoffman, 2011).  To determine the impact of changes in haematocrit on our total 
pulmonary resistance measurements we compared resting haematocrit values 
from our SL-HX (46.7 ± 0.6%; mean ± SEM) and SL-HA groups (49.4 ± 1.1%).  
Unfortunately, direct comparisons to our Sherpa group cannot be made as blood 
samples were not taken from this group.  Instead, we have selected haematocrit 
values from Sherpas from previously published literature (Winslow et al., 1989) 
and from an unpublished data set from a previous expedition to the EV-K2-CNR 
laboratory in 2008.  During this expedition, arterial blood samples were taken 
from 8 Sherpas (including 4 who participated in the current study) and analyzed 
for haematocrit.  Mean haematocrit from Winslow et al was 48.4 ± 0.8% (at an 
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altitude of 3,700m) and from our unpublished data set was 53.9 ± 2.0% (at an 
altitude of 5,050m).  Based on these data, the relative error in our measurement 
of total pulmonary resistance is less than ~10% between high altitude and sea-
level measurements.  This value is based on the curvilinear relationship between 
haematocrit and relative blood viscosity (and standardized to a blood haematocrit 
of 45%) as described previously (Hoffman, 2011).  As a result, it is unlikely that 
differences in haematocrit between Sherpas and sea-level inhabitants can 
account for the similarity in total pulmonary resistance at high altitude and can 
only account for less than ~10% of the rise in total pulmonary resistance between 
sea-level measurements.  The effect haematocrit has on blood flow through 
IPAVA is presently unknown.   
 
Conclusion 
In conclusion, we report that pulmonary vascular pressure in Sherpas is elevated 
by comparison to sea-level inhabitants at sea level but not different from sea-
level inhabitants following 3 weeks at high altitude.  We found a similar proportion 
of subjects with intracardiac shunt and blood flow through IPAVA in Sherpa 
compared to sea-level inhabitants.  At high altitude the effect of right-to-left 
shunting on PaO2 may be negligible and therefore is not a strong stimulus for 
selective adaptation for success in the high altitude environment.  Alternatively, 
chronic hypoxaemia (i.e. weeks to life-long), unlike acute hypoxaemia (i.e., 
minutes to hours), may lead to remodeling of the pulmonary vasculature such 
that blood flow through IPAVA is reduced compared to acute hypoxia.  Or 
perhaps more simply, the lack of a significant difference in cardiac output after 
acclimatization while at high altitude could be responsible for the lack of blood 
flow through IPAVA.  These hypotheses are supported by the fact that both sea-
level inhabitants and Sherpas had significantly less blood flow through IPAVA by 
comparison to either our acute hypoxia exposure or based on published studies 
of acute normobaric hypoxia where cardiac output often increases and time for 
pulmonary vascular remodeling would not be sufficient.  Taken together, blood 
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flow through PFO and IPAVA do not appear to contribute to resting 
cardiopulmonary haemodynamics in well-adapted Sherpas at high altitude. 
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Tables. 
 
Table 1. Subject characteristics and resting haemodynamics between sea-level inhabitants at sea level (SL-SL), during 
acute isocapnic hypoxia (SL-HX), following 3 weeks of high-altitude acclimatization (SL-HA), and in Sherpas at high 
altitude (5,050 m).  Subjects are further separated into groups based on their intracardiac shunt status (i.e. PFO+/PFO-). 
 SL-SL SL-HX SL-HA Sherpa 
 PFO- PFO+ Both PFO- only PFO- only PFO- PFO+ Both 
N 10 7 17 7 8 7 7 14 
Age (years) 32.6 ± 7.4 27.3 ± 6.0 30.4 ± 7.2 30.9 ± 5.3 30.0 ± 5.5 41.6 ± 17.3 25.6 ± 5.3* 33.7 ± 15.0 
Sex (M:F) 9:1 4:3 13:4 6:1 7:1 7:0 7:0 14:0 
Height (cm) 176 ± 6 177 ± 7 178 ± 6* 176 ± 7 177 ± 7 167 ± 7 168 ± 7 168 ± 7 
Body mass (kg) 80.8 ± 12.4 70.7 ± 13.0 76.6 ± 13.3 84.8 ± 13* 80.7 ± 13.4* 62.7 ± 7.5 68.6 ± 12.4 65.7 ± 10.3 
BMI (kg m-2) 26.1 ± 3.6 22.6 ± 3.1 24.6 ± 3.7 27.3 ± 3.4 26.4 ± 4.0 22.3 ± 1.2 24.3 ± 4.0 23.3 ± 3.0 
BSA (m2) 1.98 ± 0.17 1.86 ± 0.19 1.93 ± 0.18* 2.03 ± 0.18* 2.01 ± 0.18* 1.71 ± 0.14 1.78 ± 0.07 1.75 ± 0.16 
Birth Altitude (m) 275 ± 387 122 ± 162 185 ± 277 141.7 ± 185 125 ± 178 3,979 ± 247 3,884 ± 571 3,931 ± 425 
SpO2 (%) 97.7 ± 1.3 97.9 ± 1.4 97.8 ± 1.3 77.6 ± 3.9 81.2 ± 1.7 80.9 ± 3.8 83.9 ± 2.0 82.4 ± 3.3 
HR (bpm) 56.7 ± 7.1 58.7 ± 11.9 57.5 ± 9.1 66.3 ± 13.2 70.3 ± 11.3 73.9 ± 14.3 77.9 ± 13.5 75.9 ± 13.5 
MAP (mmHg) 89.8 ± 7.9 92.8 ± 8.0 91.1 ± 7.8 93.6 ± 7.0 99.3 ± 9.7 89.9 ± 7.0 94.4 ± 7.9 92.1 ± 7.5 
Qi (l min m-2) 2.05 ± 0.27 2.41 ± 0.47 2.21 ± 0.40 2.70 ± 0.73 1.91 ± 0.17 2.40 ± 0.53 2.06 ± 0.41 2.24 ± 0.49 
Values are mean ± SD. *Significantly different from Sherpa or different than PFO- within each group (P<0.05); 
Significantly different from Sherpa (P<0.001).  Definition of Abbreviations: BMI = body mass index; BSA = body surface 
area; SpO2 = oxyhaemoglobin saturation; HR = heart rate; MAP = mean arterial pressure; Qi = cardiac index. 
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Table 2.  Distribution of geographical locations and altitudes where Sherpas 
were born. 
Location Elevation 
(m) 
Frequency 
(n) 
Dingboche 4410 2 
Khumjung 3780 1 
Khunde 3840 3 
Lukla 2840 1 
Namche Bazaar 3440 1 
Pangboche 3930 1 
Pheriche 4240 4 
Thame 3750 1 
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Figures and legends. 
 
Figure 1.  (A) Pulmonary artery systolic pressure (PASP) and (B) total pulmonary 
resistance (PASP/Q) in sea-level inhabitants at sea level during rest (SL-SL; 
n=17), during acute hypoxia (SL-HX; n=7) and at high altitude (SL-HA; n=8), and 
in Sherpas at high altitude (Sherpa; n=14) and during 5 minutes of breathing 
100% oxygen (Sherpa O2; n=14).  Where appropriate groups are divided into 
their status of intracardiac shunt (i.e. PFO-/PFO+).  Values are mean ± SD.  
*P<0.01 compared to SL-SL and P<0.01 compared to SL-HA and Sherpa.  
Within each group there are no significant differences between PFO- or PFO+ 
status. 
 
Figure 2. Contrast echocardiograms (apical four-chamber view; left ventricle 
focus) of one Sherpa at 5,050m demonstrating an intracardiac shunt.  The 
sequence of images shows (A) pre-injection where no microbubbles are visible 
followed by (B) the appearance of the microbubble cloud in the right ventricle and 
the appearance of microbubbles in the left ventricle within 3 cardiac cycles 
(labeled with circles). 
 
Figure 3.  (A) Percent of subjects positive for intracardiac shunt in sea-level 
inhabitants at sea level (SL-SL) and in Sherpas at high altitude. (B) Percent of 
subjects positive for IPAVA in sea-level inhabitants during acute hypoxia (SL-
HX), at high altitude (SL-HA), and in Sherpas at high altitude who were negative 
for intracardiac shunt. 
 
Figure 4.  Contrast echocardiograms (apical four-chamber view; left ventricle 
focus) of one Sherpa showing (A) IPAVA at rest and (B) during 5 minutes of 
breathing hyperoxia (FiO2 = 1.0).  Note that microbubbles are present in the left 
ventricle in each image (labeled with circles).  Both panels A and B were 
assigned microbubble scores of 1. 
